h-d-phe-pip-arg-pna has been researched along with piperidines in 2 studies
| Studies (h-d-phe-pip-arg-pna) | Trials (h-d-phe-pip-arg-pna) | Recent Studies (post-2010) (h-d-phe-pip-arg-pna) | Studies (piperidines) | Trials (piperidines) | Recent Studies (post-2010) (piperidines) |
|---|---|---|---|---|---|
| 95 | 1 | 5 | 40,235 | 5,221 | 14,545 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gast, A; Tschopp, TB | 1 |
| Aisaka, K; Hamada, A; Hayashi, M; Okaya, Y; Wakitani, K | 1 |
2 other study(ies) available for h-d-phe-pip-arg-pna and piperidines
| Article | Year |
|---|---|
Inhibition of extrinsic and intrinsic thrombin generation by a novel synthetic thrombin inhibitor (Ro 46-6240), recombinant hirudin and heparin in human plasma.
Topics: Antithrombins; Binding Sites; Chromogenic Compounds; Dipeptides; Heparin; Hirudins; Humans; Hydrolysis; Kinetics; Naphthalenes; Piperidines; Recombinant Proteins; Thrombin | 1995 |
Inhibitory effect of JTV-803, a new cyclic guanidine derivative, on factor Xa in vitro and in vivo.
Topics: Administration, Oral; Animals; Cricetinae; Dipeptides; Dogs; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolysin; Humans; Injections, Intravenous; Isoquinolines; Macaca fascicularis; Male; Oligopeptides; Partial Thromboplastin Time; Piperidines; Pyridines; Rats; Species Specificity; Substrate Specificity; Tetrahydroisoquinolines; Thrombin; Thrombin Time; Time Factors; Trypsin | 2001 |